Literature DB >> 7608161

A novel Leydig cell cDNA-derived protein is a relaxin-like factor.

E E Büllesbach1, C Schwabe.   

Abstract

According to Burkhardt et al. (Burkhardt, E., Adham, I. M., Brosig, B., Gastmann, A., Mattei, M. G., and Engel, W. (1994) Genomics 20, 13-19) Leydig cells contain the message for a protein of the insulin/relaxin family which was named Leydig cell insulin-like protein (LEY I-L). We have synthesized the human LEY I-L according to the amino acid sequence deduced from the published cDNA structure and obtained preliminary results concerning its potential target organs and its biological activity. Leydig cell insulin-like protein binds specifically to crude membrane preparations of mouse uterus and brain and shows cross-reactivity with the relaxin receptor, but not the insulin receptor. On the basis of these observations, together with the results of earlier structure-function considerations, we suggest that the new protein is a relaxin-like factor. By itself the new factor shows no obvious effect, but when given together with relaxin it significantly enhances relaxin-mediated widening of the mouse symphysis pubis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608161     DOI: 10.1074/jbc.270.27.16011

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family.

Authors:  S B Pierce; M Costa; R Wisotzkey; S Devadhar; S A Homburger; A R Buchman; K C Ferguson; J Heller; D M Platt; A A Pasquinelli; L X Liu; S K Doberstein; G Ruvkun
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  The relaxin-like factor is a hormone.

Authors:  E E Büllesbach; R Rhodes; B Rembiesa; C Schwabe
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

Review 3.  Relaxin and its role in the development and treatment of fibrosis.

Authors:  Robert G Bennett
Journal:  Transl Res       Date:  2009-04-22       Impact factor: 7.012

4.  The structural determinants of insulin-like Peptide 3 activity.

Authors:  Ross A D Bathgate; Soude Zhang; Richard A Hughes; K Johan Rosengren; John D Wade
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-01       Impact factor: 5.555

5.  Relaxin-like factor (RLF)/insulin-like peptide 3 (INSL3) is secreted from testicular Leydig cells as a monomeric protein comprising three domains B-C-A with full biological activity in boars.

Authors:  Itaru Minagawa; Masafumi Fukuda; Hisako Ishige; Hiroshi Kohriki; Masatoshi Shibata; Enoch Y Park; Tatsuo Kawarasaki; Tetsuya Kohsaka
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

Review 6.  Divergent and convergent roles for insulin-like peptides in the worm, fly and mammalian nervous systems.

Authors:  Hiu E Lau; Sreekanth H Chalasani
Journal:  Invert Neurosci       Date:  2014-01-07

7.  A time-course study of long term over-expression of ARR19 in mice.

Authors:  Imteyaz Qamar; Mohammad Faiz Ahmad; Arul Narayanasamy
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

Review 8.  DAF-16/FoxO in Caenorhabditis elegans and Its Role in Metabolic Remodeling.

Authors:  Aleksandra Zečić; Bart P Braeckman
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.